Trials / Withdrawn
WithdrawnNCT05834621
AMNIOmics: A Prenatal Rapid Genome Validation Study
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to validate Whole Genome Sequencing (WGS) on amniotic fluid to reduce the time to diagnosis and enhance the care for the fetus/neonate.
Conditions
- Multiple Anomalies of Fetus
- Genetic Predisposition Suspected
- Amniocentesis Affecting Fetus or Newborn
- Family Members
Timeline
- Start date
- 2025-01-07
- Primary completion
- 2025-01-07
- Completion
- 2025-01-07
- First posted
- 2023-04-28
- Last updated
- 2025-09-05
Source: ClinicalTrials.gov record NCT05834621. Inclusion in this directory is not an endorsement.